TGFBR1 and gastric cancer: Based on previous data, we treated three poorly differentiated GC cell lines, AGS, SNU-1 and KATO III [14,15,16] with increasing concentration of SB431542 (0, 1, 2, 5, 10, 20 μM), a selective inhibitor of TGFBR1, for 72 h.